Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agenus Inc AGEN

Healthcare Biotechnology
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its... see more

Recent & Breaking News (NDAQ:AGEN)

Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development

Business Wire 9 days ago

Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024

Business Wire November 7, 2024

November 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - AGEN

Accesswire November 5, 2024

AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile November 5, 2024

Shareholders that lost money on Agenus Inc. (AGEN) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire November 5, 2024

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Newsfile November 5, 2024

Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update

Business Wire November 5, 2024

Agenus Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your Rights - AGEN

Accesswire November 5, 2024

FINAL AGEN DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Agenus Inc. Investors to Join the Class Action Lawsuit!

Accesswire November 5, 2024

Shareholders that lost money on Agenus Inc.(AGEN) should contact Levi & Korsinsky about pending Class Action - AGEN

PR Newswire November 5, 2024

Class Action Filed Against Agenus Inc. (AGEN) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire November 4, 2024

AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile November 4, 2024

Investors Who Lost Money on Agenus Inc. (AGEN) Should Contact Levi & Korsinsky About Pending Class Action - AGEN

Accesswire November 4, 2024

Faruqi & Faruqi Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024 - AGEN

Accesswire November 4, 2024

Agenus Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your Rights - AGEN

Accesswire November 4, 2024

November 5 Deadline: Agenus Inc Is Being Sued For Defrauding The Public And Affected Shareholders Are Urged To Contact The Schall Law Firm

Accesswire November 4, 2024

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 5, 2024 in Agenus Inc. Lawsuit - AGEN

Accesswire November 4, 2024

Shareholders of Agenus Inc. Should Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your Rights - AGEN

Accesswire November 4, 2024

FINAL REMINDER AGEN DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Agenus Inc. Investors to Participate in the Class Action Lawsuit!

Accesswire November 4, 2024

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) Shareholders

PR Newswire November 4, 2024